S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CODX · Co-Diagnostics, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$0.62
-0.02
(-3.65%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$0.62
$0.62
$0.67
52-WEEK RANGE
$0.62
$0.61
$46.50
What's happening
- CODX is down 3.65% today, trading at $0.62. — Live quote
- It's trading within 3% of its 52-week low ($0.61). (Finnhub fundamentals)
- Volume today (2,367) is well below its 3-month average of 419,410. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-1.46 actual vs. $-3.06 estimated (+52.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 4
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (7 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CODX
-87.21%
vs S&P 500
-99.98%
1-YEAR RETURN
CODX
-93.76%
vs S&P 500
-108.32%
6-MONTH RETURN
CODX
-55.66%
3-MONTH RETURN
CODX
-72.57%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-1.46
Est. $-3.06
BEAT +52.3%
2026-04-26 (Q1 2026)
$-4.06
Est. $-3.83
MISS -6.1%
2026-01-26 (Q4 2025)
$-3.64
Est. $-3.67
BEAT +0.9%
2025-10-26 (Q3 2025)
$-4.80
Est. $-4.90
BEAT +2.0%
Valuation Measures & Ratios
Enterprise Value4$1.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)6.80
Price / Book70.89
EV4 / Revenue1.74
EV4 / EBITDA0.07
Profit Margin-6523.11%
Operating Margin-6770.38%
Return on Equity (ROE8)-210.99%
Return on Assets (ROA9)-174.97%
Avg Volume (3M)419,410
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $13.1M | $4.3M | $379.0M | $309.3K | $330.1K |
| P/E | -0.45 | -0.14 | -12.29 | -0.01 | -0.01 |
| Price/Sales | 21.09 | 8.43 | 379.07 | 0.09 | 0.09 |
| Price/Book | 1.03 | 0.27 | 9.51 | 0.01 | 0.01 |
| EV/Revenue | 15.21 | -7.88 | 367.63 | -3.08 | -0.41 |
| EV/EBITDA | — | — | -11.25 | — | — |
| ROE | -228.45% | -188.81% | -77.45% | -79.99% | -71.90% |
| ROA | -175.04% | -140.89% | -68.95% | -70.07% | -61.91% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short418,934
Change from Prior Settlement+37.37%
% of Float—
Days to Cover (Short Ratio)1.19
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 2.0% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-15; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -6523.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -93.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CODX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $166.1K | $146.0K | $145.4K | $162.9K | $50.3K | $641.1K | $2.7M | $467.9K |
| Gross profit | $120.8K | -$47.8K | $119.1K | $130.8K | $28.7K | $343.7K | $2.4M | $233.3K |
| Operating income | -$6.2M | -$9.2M | -$7.0M | -$8.1M | -$8.6M | -$10.2M | -$7.7M | -$10.3M |
| Net income | -$6.3M | -$9.1M | -$5.9M | -$7.7M | -$7.5M | -$9.7M | -$7.6M | -$9.3M |
| EPS (diluted) | $-1.46 | $-4.06 | $-0.16 | $-7.00 | $-7.05 | $-0.32 | $-0.25 | $-0.31 |
| EPS (basic) | $-1.46 | $-4.06 | $-0.16 | $-7.00 | $-7.05 | $-0.32 | $-0.25 | $-0.31 |
| Operating margin | -$3.7K | -$6.3K | -$4.8K | -$4.9K | -$17.0K | -$1.6K | -$289 | -$2.2K |
| Net margin | -$3.8K | -$6.3K | -$4.0K | -$4.7K | -$15.0K | -$1.5K | -$286 | -$2.0K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $16.6M | $21.5M | $24.7M | $44.7M | $46.5M | $55.1M | $63.6M | $72.4M |
| Total liabilities | $3.9M | $5.5M | $4.1M | $4.9M | $5.3M | $7.2M | $9.7M | $8.6M |
| Stockholders' equity | $12.7M | $16.0M | $20.6M | $39.8M | $40.7M | $47.5M | $53.9M | $63.8M |
| Total current assets | $5.2M | $9.8M | $13.7M | $14.1M | $15.3M | $23.8M | $32.3M | $40.1M |
| Total current liabilities | $2.9M | $4.3M | $3.5M | $3.7M | $3.7M | $5.4M | $7.3M | $5.8M |
| Cash & equivalents | $3.6M | $8.2M | $11.9M | $11.4M | $11.1M | $1.9M | $2.9M | $10.8M |
| Marketable securities (current) | — | — | — | — | $2.2M | $19.6M | $26.8M | $26.9M |
| Accounts receivable | $52.1K | $82.3K | $190.4K | $55.9K | $211.0K | $136.4K | $132.6K | $178.2K |
| Inventory | $841.7K | $846.1K | $992.4K | $1.1M | $1.1M | $1.1M | $1.1M | $1.3M |
| Property, plant & equipment | $2.0M | $2.2M | $2.3M | $2.5M | $2.7M | $2.6M | $2.8M | $3.0M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible assets | $7.2M | $7.2M | $7.2M | $26.1M | $26.1M | $26.1M | $26.1M | $26.2M |
| Accounts payable | $1.1M | $2.0M | $1.9M | $1.5M | $1.6M | $2.7M | $3.3M | $2.2M |
| Accrued liabilities | $899.2K | $1.4M | $865.3K | $1.2M | $1.0M | $1.6M | $2.6M | $1.8M |
| Deferred revenue (current) | $28.6K | $600 | $14.8K | $45.6K | $45.9K | $40.9K | $40.9K | $60.5K |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $70.5K | $69.2K | $67.7K | $53.0K | $41.0K | $38.4K | $37.9K | $36.8K |
| Retained earnings | -$95.8M | -$89.5M | -$80.4M | -$54.2M | -$48.3M | -$40.6M | -$33.5M | -$22.0M |
| Accumulated other comprehensive income (loss) | — | — | — | $94.9K | $134.1K | $330.7K | $418.4K | $408.4K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.2M | -$7.8M | -$6.2M | -$5.9M | -$8.3M | -$8.7M | -$8.2M | -$7.2M |
| Investing cash flow | -$168.3K | -$142.0K | -$329.4K | $2.2M | $17.1M | $7.4M | $266.0K | $4.2M |
| Financing cash flow | $2.7M | $4.3M | $7.0M | $4.1M | $429.0K | $354.7K | $103.9K | — |
| Free cash flow | -$7.2M | -$8.0M | -$6.3M | -$6.0M | -$8.7M | -$8.8M | -$8.3M | -$7.4M |
| Capital expenditures | $18.3K | $142.0K | $132.0K | $75.1K | $401.1K | $91.9K | $73.0K | $174.4K |
| Depreciation & amortization | — | — | — | $267.4K | $291.4K | $280.4K | $357.1K | $351.2K |
| Share-based compensation | $213.8K | $219.1K | $292.0K | $500.6K | $580.3K | $875.2K | $1.3M | $1.0M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | -$33.9K | -$103.9K | $130.8K | -$164.2K | $57.2K | $8.0K | -$69.0K | -$324.1K |
| Change in inventory | -$35.8K | -$174.2K | -$9.5K | -$38.4K | -$56.7K | -$26.7K | -$31.7K | -$117.4K |
| Purchases of investments | — | — | $0 | $2.4K | $143.8K | $6.4M | $13.4M | $13.7M |
| Share repurchases | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $622.5K | $3.9M | $6.8M | $34.2M | $97.9M |
| Gross profit | $400.1K | $2.9M | $2.6M | $28.7M | $86.3M |
| Operating income | -$50.2M | -$40.1M | -$42.7M | -$27.0M | $46.1M |
| Net income | -$46.9M | -$37.6M | -$35.3M | -$14.2M | $36.7M |
| EPS (diluted) | $-35.25 | $-37.22 | $-1.20 | $-0.45 | $1.23 |
| EPS (basic) | $-35.25 | $-37.22 | $-1.20 | $-0.45 | $1.27 |
| Operating margin | -$8.1K | -$1.0K | -$627 | -$79 | $47 |
| Net margin | -$7.5K | -$961 | -$519 | -$42 | $37 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $24.7M | $63.6M | $95.3M | $123.1M | $160.0M |
| Total liabilities | $4.1M | $9.7M | $9.3M | $8.6M | $25.6M |
| Stockholders' equity | $20.6M | $53.9M | $85.6M | $114.5M | $134.5M |
| Total current assets | $13.7M | $32.3M | $62.1M | $92.7M | $115.1M |
| Total current liabilities | $3.5M | $7.3M | $5.7M | $3.9M | $12.6M |
| Cash & equivalents | $11.9M | $2.9M | $14.9M | $23.0M | $88.6M |
| Marketable securities (current) | — | $26.8M | $43.6M | $58.3M | $1.3M |
| Accounts receivable | $190.4K | $132.6K | $303.9K | $3.5M | $20.8M |
| Inventory | $992.4K | $1.1M | $1.7M | $5.3M | $2.0M |
| Property, plant & equipment | $2.3M | $2.8M | $3.0M | $2.5M | $1.9M |
| Goodwill | — | — | — | — | $14.7M |
| Intangible assets | $7.2M | $26.1M | $26.4M | $26.8M | $27.2M |
| Accounts payable | $1.9M | $3.3M | $1.5M | $952.3K | $607.5K |
| Accrued liabilities | $865.3K | $2.6M | $2.2M | $934.4K | $3.9M |
| Deferred revenue (current) | $14.8K | $40.9K | $362.4K | — | $150.0K |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $67.7K | $37.9K | $36.1K | $34.8K | $33.8K |
| Retained earnings | -$80.4M | -$33.5M | $4.6M | $39.9M | $54.2M |
| Accumulated other comprehensive income (loss) | — | $418.4K | $146.7K | $293.1K | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$29.1M | -$29.2M | -$22.1M | $6.6M | $41.1M |
| Investing cash flow | $26.3M | $17.1M | $15.4M | -$58.2M | $4.1M |
| Financing cash flow | $11.8M | $103.9K | -$1.4M | -$14.0M | $450.4K |
| Free cash flow | -$29.8M | -$29.9M | -$23.4M | $5.1M | $40.4M |
| Capital expenditures | $700.0K | $748.4K | $1.4M | $1.4M | $669.5K |
| Depreciation & amortization | — | $1.4M | $1.2M | $1.3M | $335.4K |
| Share-based compensation | $2.2M | $5.4M | $8.3M | $7.5M | $5.5M |
| Deferred income taxes | — | — | -$2.4M | -$4.8M | $930.1K |
| Change in accounts receivable | $31.8K | -$186.4K | -$2.5M | -$14.9M | $8.7M |
| Change in inventory | -$131.3K | -$265.5K | -$413.1K | $3.7M | -$5.7M |
| Purchases of investments | $6.6M | $40.8M | $110.5M | $68.0M | — |
| Share repurchases | — | — | $1.4M | $14.2M | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CODX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-05-23 to 2026-05-23
Recent transactions
- Most recent: Egan Dwight H (Chief Executive Officer) — Grant / award of 4,584 shares on 2026-05-23.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Egan Dwight H | Chief Executive Officer | Grant / award | 2026-05-23 | 4,584 |
| Brown Brian Lee | Chief Financial Officer | Grant / award | 2026-05-23 | 3,750 |
| Abbott Richard David | President | Grant / award | 2026-05-23 | 1,890 |
| Murphy Edward L. | Reporting person | Grant / award | 2026-05-23 | 1,695 |
| SERBIN RICHARD S | Reporting person | Grant / award | 2026-05-23 | 1,695 |
| Durenard Eugene | Reporting person | Grant / award | 2026-05-23 | 1,695 |
| NELSON JAMES B | Reporting person | Grant / award | 2026-05-23 | 1,695 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-05-23 | Egan Dwight H | Chief Executive Officer | Grant / award | 4,584 | $0.00 |
| 2026-05-23 | Egan Dwight H | Chief Executive Officer | Disposition to issuer | 1,633 | $5.07 |
| 2026-05-23 | Brown Brian Lee | Chief Financial Officer | Grant / award | 3,750 | $0.00 |
| 2026-05-23 | Brown Brian Lee | Chief Financial Officer | Disposition to issuer | 1,350 | $5.07 |
| 2026-05-23 | Abbott Richard David | President | Grant / award | 1,890 | $0.00 |
| 2026-05-23 | Abbott Richard David | President | Disposition to issuer | 680 | $5.07 |
| 2026-05-23 | Murphy Edward L. | Reporting person | Grant / award | 1,695 | $0.00 |
| 2026-05-23 | SERBIN RICHARD S | Reporting person | Grant / award | 1,695 | $0.00 |
| 2026-05-23 | Durenard Eugene | Reporting person | Grant / award | 1,695 | $0.00 |
| 2026-05-23 | NELSON JAMES B | Reporting person | Grant / award | 1,695 | $0.00 |
| 2025-11-23 | Murphy Edward L. | Reporting person | Grant / award | 57,499 | $0.00 |
| 2025-11-23 | Brown Brian Lee | Chief Financial Officer | Grant / award | 134,167 | $0.00 |
| 2025-11-23 | Brown Brian Lee | Chief Financial Officer | Disposition to issuer | 40,723 | $0.35 |
| 2025-11-23 | Abbott Richard David | President | Grant / award | 56,667 | $0.00 |
| 2025-11-23 | Abbott Richard David | President | Disposition to issuer | 17,200 | $0.35 |
| 2025-11-23 | Egan Dwight H | Chief Executive Officer | Grant / award | 163,333 | $0.00 |
| 2025-11-23 | Egan Dwight H | Chief Executive Officer | Disposition to issuer | 49,575 | $0.35 |
| 2025-11-23 | SERBIN RICHARD S | Reporting person | Grant / award | 57,499 | $0.00 |
| 2025-11-23 | Durenard Eugene | Reporting person | Grant / award | 57,499 | $0.00 |
| 2025-11-23 | NELSON JAMES B | Reporting person | Grant / award | 57,499 | $0.00 |
| 2025-05-23 | Egan Dwight H | Chief Executive Officer | Grant / award | 163,334 | $0.00 |
| 2025-05-23 | Egan Dwight H | Chief Executive Officer | Disposition to issuer | 51,697 | $0.24 |
| 2025-05-23 | Brown Brian Lee | Chief Financial Officer | Grant / award | 134,166 | $0.00 |
| 2025-05-23 | Brown Brian Lee | Chief Financial Officer | Disposition to issuer | 48,161 | $0.24 |
| 2025-05-23 | Abbott Richard David | President | Grant / award | 20,000 | $0.00 |
| 2025-05-23 | Abbott Richard David | President | Disposition to issuer | 7,180 | $0.24 |
| 2025-05-23 | SERBIN RICHARD S | Reporting person | Grant / award | 48,334 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:15 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-15 | 8-K | 2026-10-14 | View on SEC.gov → |
| 2026-10-13 | 8-K | 2026-10-09 | View on SEC.gov → |
| 2026-10-05 | 8-K | 2026-09-30 | View on SEC.gov → |
| 2026-09-25 | 8-K | 2026-09-03 | View on SEC.gov → |
| 2026-09-16 | 8-K | 2026-09-16 | View on SEC.gov → |
| 2026-09-16 | 8-K | 2026-09-16 | View on SEC.gov → |
| 2026-09-15 | 8-K | 2026-08-25 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-09-02 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-09-03 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-13 | View on SEC.gov → |
| 2026-07-31 | 8-K | 2026-07-30 | View on SEC.gov → |
Recent news
Headlines about CODX (Co-Diagnostics, Inc.). Links open the publisher — we don’t host full articles.
-
Co-Diagnostics, Inc. (CODX) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Co-Diagnostics, Inc. (CODX) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
Yahoo · 2026-10-20 -
Form PRE 14A CO-DIAGNOSTICS For: 19 October By Investing.com
Investing.com India · 2026-10-19 -
Co-Diagnostics, Inc. Stock Price Today | CODX Live Chart & News
Traders Union · 2026-10-18 -
Co-Diagnostics, Inc. Share Price Live Today – NASDAQ:CODX Stock Price, Chart, News, History
Upstox · 2026-10-16 -
Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection
Yahoo · 2026-10-15 -
Russian authorities had not identified plague, WHO reported. Co-Diagnostics has not started a plague test.
Stock Titan · 2026-10-15
No headlines in this category right now — try “All”.